1. Home
  2. TG vs BIOA Comparison

TG vs BIOA Comparison

Compare TG & BIOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tredegar Corporation

TG

Tredegar Corporation

N/A

Current Price

$5.58

Market Cap

239.6M

Sector

Industrials

ML Signal

N/A

Logo BioAge Labs Inc.

BIOA

BioAge Labs Inc.

N/A

Current Price

$5.44

Market Cap

255.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TG
BIOA
Founded
1988
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
239.6M
255.6M
IPO Year
1994
2024

Fundamental Metrics

Financial Performance
Metric
TG
BIOA
Price
$5.58
$5.44
Analyst Decision
Buy
Analyst Count
0
10
Target Price
N/A
★ $28.89
AVG Volume (30 Days)
273.7K
★ 739.5K
Earning Date
11-06-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 151.06
66.21
EPS
★ 0.26
N/A
Revenue
★ $800,821,000.00
$8,995,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$83.62
P/E Ratio
$21.79
★ N/A
Revenue Growth
★ 8.29
N/A
52 Week Low
$5.26
$4.81
52 Week High
$10.53
$25.96

Technical Indicators

Market Signals
Indicator
TG
BIOA
Relative Strength Index (RSI) 28.75 39.92
Support Level N/A $4.81
Resistance Level $8.15 $6.30
Average True Range (ATR) 0.42 0.47
MACD -0.19 0.10
Stochastic Oscillator 12.52 35.87

Price Performance

Historical Comparison
TG
BIOA

About TG Tredegar Corporation

Tredegar Corp is engaged in the manufacture of aluminum extrusions and polyethylene and polypropylene plastic films. It produces surface protection films, packaging films and films for other markets. The company continues to have two reportable segments: Aluminum Extrusions and High Performance Films. The majority of the revenue is derived form the Aluminum Extrusions segment which produces high-quality, soft and medium strength alloyed aluminum extrusions, custom fabricated and finished, for the building and construction, automotive and transportation, consumer durables goods, machinery and equipment, electrical and renewable energy, and distribution markets.

About BIOA BioAge Labs Inc.

Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging. The company's technology platform and differentiated human datasets enable the identification of targets based on insights into molecular changes that drive aging. The Company operates and manages its business as one reportable and operating segment, which is the business of extending healthy human life by targeting molecular causes of aging.

Share on Social Networks: